Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia

Cancer Nursing

Volumn 36, Issue 5, 2013, Pages

  Smith, Ellen M Lavoie ^a   Li, Lang ^b   Hutchinson, Raymond J ^c   Ho, Richard ^d   Burnette, W Bryan ^d   Wells, Elizabeth ^e   Bridges, Celia ^a   Renbarger, Jamie ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b INDIANA UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^d MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^e GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Children; Leukemia; Neuropathic Pain; Peripheral Neuropathy; Reliability; Sensitivity; Total Neuropathy Score; Validity; Vincristine

Indexed keywords

VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; DRUG INDUCED DISEASE; FACES PAIN SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; NEUROPATHIC PAIN; PERIPHERAL NEUROPATHY; PHARMACOLOGICAL PARAMETERS; PRESCHOOL CHILD; PRIORITY JOURNAL; RELIABILITY; SCHOOL CHILD; TENDON REFLEX; VALIDITY;

ADOLESCENT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; FEASIBILITY STUDIES; FEMALE; HUMANS; INFANT; MALE; NURSING ASSESSMENT; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; TISSUE DISTRIBUTION; UNITED STATES; VINCRISTINE;

EID: 84883310212     PISSN: 0162220X     EISSN: 15389804     Source Type: Journal    
DOI: 10.1097/NCC.0b013e318299ad23     Document Type: Article

References (37)

1. Vainionpaa L, Kovala T, Tolonen U, Lanning M. Vincristine therapy for children with acute lymphoblastic leukemia impairs conduction in the entire peripheral nerve. Pediatr Neurol. 1995;13(4):314-318
2. Ramchandren S, Leonard M, Mody RJ, et al. Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia. J Peripher Nerv Syst. 2009;14(3):184-189
3. Dougherty P, Cata J, Burton A, Vu K, Weng H. Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain. J Pain SymptomManage. 2007; 33(2):166-179
4. Windebank AJ, GrisoldW. Chemotherapy-induced neuropathy. J Peripher Nerv Syst. 2008;13:27-46
5. Hausheer FH, Schilsky RL, Bain S, Berghorn EJ, Lieberman F. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Semin Oncol. 2006;33(1):15-49
6. Ogawa T, Mimura Y, Kato H, Ootsubo S, Murakoshi M. The usefulness of rabbits as an animal model for the neuropathological assessment of neurotoxicity following the administration of vincristine. Neurotoxicology. 2000;21(4):501-511
7. Visovsky C, Daly BJ. Clinical evaluation and patterns of chemotherapyinduced peripheral neuropathy. J Am Acad Nurse Pract. 2004;16(8):353-359
8. Reinders Messelink HA, Schoemaker MM, Hofte M, et al. Fine motor and handwriting problems after treatment for childhood acute lymphoblastic leukemia. Med Pediatr Oncol. 1996;27(6):551-555
9. Bakitas MA. Background noise: The experience of chemotherapy-induced peripheral neuropathy. Nurs Res. 2007;56(5):323-331
10. Meyer-Rosberg K, Kvarnstrom A, Kinnman E, Gordh T, Nordfors LO, Kristofferson A. Peripheral neuropathic painVa multidimensional burden for patients. Eur J Pain. 2001;5(4):379-389
11. Nail L. Symptoms and physical function following treatment among people with chemotherapy-induced peripheral neuropathy. Oncol Nurs Forum. 2011;38(1):A48-A49
12. Berger A, Dukes E, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain. 2004;5(3):143-149
13. Cavaletti G, Jann S, Pace A, et al. Multi-center assessment of the total neuropathy score for chemotherapy-induced peripheral neurotoxicity. J Peripher Nerv Syst. 2006;11(2):135-141
14. Postma TJ, Heimans JJ, Muller MJ, Ossenkoppele GJ, Vermorken JB, Aaronson NK. Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy. Ann Oncol. 1998;9(7):739-744
15. Kuroi K, Shimozuma K, Ohashi Y, et al. Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study). Support Care Cancer. 2009;17:1071-1080
16. Lavoie Smith EM, Cohen JA, Pett MA, Beck SL. The validity of neuropathy and neuropathic pain measures in patients with cancer receiving taxanes and platinums. Oncol Nurs Forum. 2011;38(2):133-142
17. Cavaletti G, Cornblath DR, Merkies IS, et al. The chemotherapyinduced peripheral neuropathy outcome measures standardization study: From consensus to the first validity and reliability findings. Ann Oncol. 2013;24(2):454-462
18. Griffith K, Merkies ISJ, Hill E, Cornblath D. Measures of chemotherapyinduced peripheral neuropathy: A systematic review of psychometric properties. J Peripher Nerv Syst. 2010;15(4):314-325
19. Gilchrist LS. Measuring chemotherapy-induced peripheral neuropathy in children: Development of the Ped-mTNS and pilot study results. Rehabilitation Oncology. 2009;27(3):7-15
20. Gilchrist LS, Tanner L. The pediatric-modified total neuropathy score: A reliable and valid measure of chemotherapy-induced peripheral neuropathy in children with non-CNS cancers. Support Care Cancer. 2013;21(3):847-856
21. Stinson J, Kavanagh T, Yamada J, Gill N, Stevens B. Systematic review of the psychometric properties, interpretability and feasibility of selfreport pain intensity measures for use in clinical trials in children and adolescents. Pain. 2006;125(1-2):143-157
22. von Baeyer CL, Spagrud LJ. Systematic review of observational (behavioral) measures of pain for children and adolescents aged 3 to 18 years. Pain. 2007;127(1-2):140-150
23. McGrath PJ, Walco GA, Turk DC, et al. Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations. J Pain. 2008;9(9):771-783
24. Smith EL, Beck SL, Cohen J. The total neuropathy score (TNS): A tool for measuring chemotherapy-induced peripheral neuropathy. Oncol Nurs Forum. 2008;35(102):96-102
25. Smith EM, Cohen JA, Pett MA, Beck SL. The reliability and validity of a modified total neuropathy score-reduced and neuropathic pain severity items when used to measure chemotherapy-induced peripheral neuropathy in patients receiving taxanes and platinums. Cancer Nurs. 2010;33(3):173-183
26. Cornblath DR, Chaudhry V, Carter K, et al. Total neuropathy score: Validation and reliability study. Neurology. 1999;53(8):1660-1664
27. Chaudhry V, Eisenberger MA, Sinibaldi VJ, Sheikh K, Griffin JW, Cornblath DR. A prospective study of suramin-induced peripheral neuropathy. Brain. 1996;119(pt 6):2039-2052
28. Chaudhry V, Rowinsky EK, Sartorius SE, Donehower RC, Cornblath DR. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studies. Ann Neurol. 1994;35(3):304
29. Chaudhry V, Cornblath D, Corse A, Freimer M, Simmons-O'Brien E, VogelsangG. Thalidomide-induced neuropathy.Neurology. 2002;59:1872-1875
30. Wampler MA, Miaskowski C, Hamel K, Byl N, Rugo H, Topp LS. The modified total neuropathy score: A clinically feasible and valid measure of taxane-induced peripheral neuropathy in women with breast cancer. Support Oncol. 2006;4(8):W9YW16
31. Postma TJ, Heimans JJ. Grading of chemotherapy-induced peripheral neuropathy. Ann Oncol. 2000;11(5):509-513
32. Hockenberry MJ, Wilson D, Winkelstein ML, eds. Wong's Essentials of Pediatric Nursing. 7th ed. St Louis, MO: Elsevier Mosby; 2005
33. Ferketich S. Focus on psychometrics: Internal consistency estimates of reliability. Res Nurs Health. 1990;13(6):437-440
34. Devillis RF. Scale Development: Theory and Applications. 2nd ed. Thousand Oaks, CA: Sage Publications; 2003
35. Strickland OL. Internal consistency analysis: Making the most of what you've got. J Nurs Meas. 1996;4(1):3-4
36. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-174
37. Williams PD, Williams AR, Kelly KP, et al. A symptom checklist for children with cancer: The Therapy-Related Symptom Checklist-Children. Cancer Nurs. 2012;35(2):89-98